Date published: 2026-6-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

DSPP Inhibitors

DSPP inhibitors belong to a distinctive chemical class primarily known for their capacity to modulate a specific biological process. These inhibitors are designed to target Dentin Sialophosphoprotein (DSPP), a crucial protein found in teeth and bones. DSPP is essential for the development and mineralization of dentin, a hard tissue that constitutes a major component of teeth. It plays a pivotal role in dentinogenesis, controlling the formation and growth of dentin by regulating the deposition of minerals in the extracellular matrix. DSPP inhibitors are intricately engineered compounds that aim to regulate the activity of DSPP, influencing the biomineralization process in teeth and bones. The design and development of DSPP inhibitors involve a deep understanding of the structural and functional properties of DSPP. These inhibitors often act by interacting with specific regions of the DSPP protein, thereby modulating its function and subsequent downstream effects. Researchers explore various molecular strategies to design potent DSPP inhibitors, utilizing computational techniques and experimental approaches to identify binding sites and mechanisms of action. The goal is to create compounds that can selectively inhibit DSPP without significantly affecting other crucial biological processes. The study of DSPP inhibitors not only provides insights into the fundamental mechanisms of dentinogenesis and biomineralization but also offers avenues for applications in a range of fields where the modulation of DSPP could have notable effects.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sitagliptin

486460-32-6sc-482298
sc-482298A
sc-482298B
25 mg
100 mg
1 g
$213.00
$473.00
$733.00
10
(0)

Inhibits DPP-4, an enzyme responsible for degrading incretin hormones. Increases insulin release and decreases glucagon secretion, thus lowering blood glucose.

Vildagliptin

274901-16-5sc-208485
10 mg
$176.00
4
(1)

Blocks DPP-4 activity, prolonging the action of incretin hormones. Enhances insulin secretion and reduces glucagon release, aiding in blood sugar control.

Saxagliptin

361442-04-8sc-473161
1 mg
$360.00
(0)

Selectively inhibits DPP-4, leading to increased incretin levels. Enhances insulin synthesis and release while reducing glucagon, helping manage blood glucose.

Linagliptin

668270-12-0sc-364721
sc-364721A
5 mg
10 mg
$260.00
$426.00
2
(0)

Binds tightly to DPP-4, inhibiting its activity. Enhances insulin secretion and reduces glucagon levels, assisting in the regulation of blood sugar.

Anagliptin

739366-20-2sc-507278
5 mg
$280.00
(0)

Acts as a potent DPP-4 inhibitor, leading to improved glycemic control. Increases active incretin levels, enhancing insulin secretion and suppressing glucagon.

Teneligliptin

760937-92-6 (free base)sc-475074
25 mg
$260.00
1
(0)

Inhibits DPP-4, increasing GLP-1 and GIP levels. Enhances insulin secretion and lowers glucagon release, contributing to better management of blood glucose.

Gemigliptin tartrate

1374639-74-3sc-507281
10 mg
$165.00
(0)

Binds to and inhibits DPP-4 enzyme activity. Elevates incretin hormone levels, promoting insulin release and reducing glucagon secretion for glucose regulation.

Omarigliptin

1226781-44-7sc-507282
5 mg
$337.00
(0)

Long-acting DPP-4 inhibitor. Raises incretin hormone concentrations, leading to enhanced insulin secretion and decreased glucagon, aiding blood glucose control.

Trelagliptin

865759-25-7sc-507285
5 mg
$405.00
(0)

Provides sustained DPP-4 inhibition. Increases incretin hormones, which stimulate insulin secretion and suppress glucagon, contributing to better glycemic control.